Theragnostics partners with PCCA for UK distribution

Theragnostics Limited (Theragnostics) is pleased to announce the completion of an Exclusive Product Supply and Distribution Agreement with PCCA Ltd for distribution of Theragnostics proprietary prostate cancer imaging THP-PSMA kits in the United Kingdom. Under the agreement, PCCA will distribute THP-PSMA kits for use in compassionate use or “specials” clinical studies in the United Kingdom.

THP-PSMA is currently in clinical development with Theragnostics sponsored Phase II clinical trials ongoing. The THP-PSMA kit enables rapid one-step formation of 68Ga-THP-PSMA which is applied to positron emission tomography (PET) diagnostic imaging in prostate cancer patients.

PCCA Ltd (formerly known as The Specials Laboratory) based in Northumberland, UK are an award-winning company delivering unlicensed medicines (Specials) and Investigational Medicinal Products (IMPs) to thousands of community and hospital pharmacists and doctors throughout the UK and Ireland – usually within 24 hours of an order being placed. For further information visit